Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-24 @ 10:06 PM
NCT ID:
NCT02263235
Eligibility Criteria:
Inclusion Criteria:
* Reports written consent, informed and signed by the patient and a trusted person
* Subject member or beneficiary of a social security system
Specific criteria for group 1 and 2B :
* Age between 55 and 85 years old for patients
* Subject with AD or other neurodegenerative disease (frontotemporal dementia, dementia with Lewy bodies, Parkinson disease)
* Subjects with chronic adult hydrocephalus (HCA) requiring depletion lumbar puncture (PL)
Specific criteria for group 2A :
\- Adult patient requiring neurosurgery with CSF shunt (subject with brain trauma, acute hydrocephaly) and favorable evolution that allows removal of the shunt
Exclusion Criteria:
* Patient deprived of liberty by judicial or administrative decision
* Major protected by law
* Pregnancy, women of childbearing age with risk of pregnancy, or breast-feeding
* Presence of a transmissible viral disease (HlV, hepatitis B and C)
* Patient included in a clinical trial
* lnadequate cardiac, hepatic or severe renal disfunction
* Disease amino acid metabolism (Leucinose..)
Exclusion Criteria:
* Information clinical and para-clinical insufficient or unavailable
* Patient deprived of liberty by judicial or administrative decision
* Major protected by law
* Pregnancy, women of childbearing age with risk of pregnancy, or breast
* feeding
* Presence of a transmissible viral disease (HIV, hepatitis B and C)
* Patient included in a clinical trial
* Patient exclusion period relative to another protocol or for which the maximum annual compensation of 4500€ has been reached
* Inadequate cardiac, hepatic or severe renal
* Disease amino acid metabolism (Leucinose..)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
85 Years
Study:
NCT02263235
Study Brief:
Protocol Section:
NCT02263235